Medicamen Biotech Ltd. - MEDICAMEQ, 531146 corporate action history

Medicamen Biotech Ltd. NSE: MEDICAMEQ | BSE: 531146

Expensive Performer

Download real time

395.00 -1.70 (-0.43%)

37.30% Fall from 52W High

20,493

NSE+BSE Volume

NSE 31 Jul, 2025 11:51 AM (IST)

Medicamen Biotech Ltd. Bonus history

Medicamen Biotech Ltd. has not announced any bonus since Jan 1, 2000.

See all forthcoming Bonus and Splits

Medicamen Biotech Ltd. Split history

Medicamen Biotech Ltd. has not split the face value of the share since Jan 1, 2000.

See all forthcoming Bonus and Splits

Dividend history for Medicamen Biotech Ltd.

Medicamen Biotech Ltd. has declared 8 dividends since Sept. 21, 2010.

In the past 12 months, Medicamen Biotech Ltd. has declared an equity dividend amounting to ₹1.00 per share.

At the current share price of ₹395.0000, Medicamen Biotech Ltd.'s dividend yield is 0.25%.

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
19 Sep 2024	1.00	FINAL	-	Equity Share
20 Sep 2023	1.00	FINAL	-	Equity Share
19 Sep 2022	1.00	FINAL	-	Equity Share
16 Sep 2021	1.00	FINAL	-	Equity Share
17 Sep 2020	0.50	FINAL	-	Equity Share
17 Sep 2019	1.00	FINAL	18 Sep 2019	Equity Share
08 Aug 2017	1.00	INTERIM	09 Aug 2017	Equity Share
21 Sep 2010	0.75	FINAL	-	Equity Share

See all forthcoming dividends Check out stocks with top dividend.

Board Meetings - Medicamen Biotech Ltd.

The latest board meeting for Medicamen Biotech Ltd. took place on 30 May 2025, for the purpose of Audited Results & Final Dividend

Ex-Date	Purpose	Notes
30 May 2025	Audited Results & Final Dividend	-
26 Feb 2025	Preferential issue of shares	-
11 Feb 2025	Quarterly Results	-
14 Nov 2024	Quarterly Results	-
13 Aug 2024	Quarterly Results	-
29 May 2024	Audited Results & Final Dividend	-
12 Feb 2024	Quarterly Results	-
10 Nov 2023	Quarterly Results	-
08 Aug 2023	Quarterly Results	-
29 May 2023	Audited Results & Final Dividend	-

See all Board Meetings for Medicamen Biotech Ltd.

Medicamen Biotech Ltd. Rights history

Medicamen Biotech Ltd. has not issued any rights since Jan 1, 2000.

See all Rights History for Medicamen Biotech Ltd.

Is Medicamen Biotech Ltd. worth buying?

39 Votes:

Buy 76.92%

Sell 17.95%

Hold 5.13%